New Study Questions the Value of Common Meniscus Surgery

A landmark 10-year clinical trial has challenged a widely performed knee procedure. Researchers found that arthroscopic partial meniscectomy—trimming a torn meniscus—offers no meaningful pain relief compared to a sham surgery. Even more concerning, patients who underwent the real operation experienced worse long-term outcomes, including more symptoms, reduced function, faster osteoarthritis progression, and a higher risk of additional surgery. These results are prompting a re-evaluation of a surgery performed hundreds of thousands of times each year.

What was the major finding of the 10-year study on meniscus surgery?

The study, a randomized controlled trial, followed patients for a decade. It compared those who received arthroscopic partial meniscectomy (trimming the torn meniscus) with those who had a placebo surgery—a procedure where the surgeon made incisions but did not actually cut the meniscus. The key finding: there was no significant difference in pain relief or functional improvement between the two groups. In fact, patients in the real surgery group reported more symptoms and lower function at the 10-year mark. The authors concluded that the surgery provides no benefit over placebo and may actually be harmful in the long run.

How did the study compare the surgery to a placebo?

The trial used a rigorous double-blind design: neither the patients nor the assessors knew who received the real meniscus trimming and who had the placebo. During the placebo procedure, surgeons made the same skin incisions and used the same arthroscopic equipment, but they did not cut or remove any meniscus tissue. Participants followed identical rehab protocols. At various time points—including 1, 2, 5, and 10 years—researchers measured pain, knee function, and X-ray evidence of arthritis. The placebo group consistently reported similar levels of pain relief as the surgery group, undermining decades of belief in the operation's effectiveness.

What were the long-term outcomes for patients who had the real surgery?

Beyond showing no benefit, the real surgery group actually fared worse over the long term. Specifically, they had:

• Higher scores on pain and symptom scales
• Reduced knee function in daily activities
• Faster progression of osteoarthritis visible on X-rays
• A greater likelihood of needing additional knee surgeries, including total knee replacement

These outcomes suggest that removing meniscal tissue accelerates joint degeneration, likely because the meniscus plays a crucial role in cushioning and stabilizing the knee. The study's lead author emphasized that the procedure may be doing more harm than good.

Why has meniscus surgery been so common despite these findings?

Arthroscopic partial meniscectomy is one of the most frequent orthopedic surgeries worldwide—over half a million performed annually in the United States alone. Its popularity grew from historical observational studies that reported high patient satisfaction and rapid relief. However, those studies lacked proper control groups. The powerful placebo effect of surgery (the belief that an operation must help) likely influenced earlier results. Additionally, many surgeons and patients equate immediate post-op improvement with effectiveness, ignoring long-term consequences. The new trial provides strong evidence that the surgery's perceived benefits were largely due to the natural healing process and placebo, not the actual removal of meniscus tissue.

What does this mean for patients with meniscus tears today?

These findings challenge the routine use of meniscus trimming for degenerative tears—torn menisci that occur with aging and wear. For many patients, especially those over 40, the study suggests that non-surgical management should be the first line of treatment. Physical therapy, activity modification, and anti-inflammatory medications can be highly effective. Even for traumatic tears in younger athletes, the decision to operate should be made carefully, weighing the potential for faster osteoarthritis. The study does not apply to all meniscus injuries (e.g., bucket-handle tears causing locking), but it calls for a dramatic shift in clinical practice: think twice before cutting the meniscus.

Are there alternative treatments for meniscus damage?

Yes, and many are supported by growing evidence. For degenerative tears, a structured physical therapy program can improve strength, range of motion, and pain in 80% of patients within 6–12 weeks. Other options include:

1. Activity modification — avoiding high-impact sports that load the knee.
2. Anti-inflammatory medications (NSAIDs) or corticosteroid injections for flare-ups.
3. Meniscus repair — stitching the torn tissue back together—though this is only possible for certain tear types and locations.
4. Platelet-rich plasma (PRP) therapy — still under investigation but promising for some patients.

The first step is an accurate diagnosis—MRI to assess tear type—and a conversation with an orthopedic surgeon who stays current with the latest evidence. In many cases, avoiding surgery is the best choice for long-term knee health.